unknown
Stage
About
Fortis Medical Devices develops cueStim, a non-invasive medical device intended to reduce the frequency and severity of Freezing of Gait (FoG) episodes in people with Parkinson's disease. The company's device is being developed as a Class II De Novo medical device and has been designated an FDA Breakthrough Technology and included in the FDA TAP pilot program.
Explore Fortis Medical Devices's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.